Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $1.92 Million - $2.26 Million
-6,900 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $1.62 Million - $2.01 Million
6,900 New
6,900 $1.98 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $49.4 Million - $61.3 Million
-219,598 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $9.82 Million - $12.1 Million
-44,312 Reduced 16.79%
219,598 $50.7 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $5.35 Million - $6.93 Million
-29,655 Reduced 10.1%
263,910 $60.6 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $4.34 Million - $5.62 Million
-26,436 Reduced 8.26%
293,565 $54.8 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $1.98 Million - $2.62 Million
15,151 Added 4.97%
320,001 $53.4 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $2.57 Million - $2.97 Million
17,545 Added 6.11%
304,850 $44.6 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $1.89 Million - $2.28 Million
-13,880 Reduced 4.61%
287,305 $46.8 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $4.14 Million - $5.12 Million
-34,748 Reduced 10.34%
301,185 $41.7 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $9.23 Million - $11.4 Million
-86,281 Reduced 20.44%
335,933 $44.1 Million
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $4.99 Million - $5.43 Million
-46,772 Reduced 9.97%
422,214 $47.4 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $7.54 Million - $8.8 Million
68,018 Added 16.96%
468,986 $52.3 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $8.1 Million - $9.54 Million
-72,810 Reduced 15.37%
400,968 $51.7 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $1.54 Million - $1.73 Million
14,577 Added 3.17%
473,778 $54.1 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $1.57 Million - $1.96 Million
-18,289 Reduced 3.83%
459,201 $49 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $2.47 Million - $2.84 Million
-32,686 Reduced 6.41%
477,490 $40.7 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $3.27 Million - $3.86 Million
44,081 Added 9.46%
510,176 $39.3 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $1.65 Million - $1.77 Million
-20,113 Reduced 4.14%
466,095 $39.4 Million
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $266,353 - $295,626
-3,456 Reduced 0.71%
486,208 $41.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
489,664
489,664 $40.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.